MELISSA WELCH: Open Payments
NPI 1780954784 · NAPERVILLE, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$477 in 23 payments from 10 companies in 2025. Trend: 2023 $860 · 2024 $1,024 · 2025 $477
Food & beverage: $477
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $97 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $78 |
| Teva Pharmaceuticals USA, Inc. | 3 | $66 |
| Neurocrine BioSciences, Inc. | 3 | $59 |
| Corium, LLC | 4 | $46 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $40 |
| Tris Pharma Inc | 1 | $25 |
| Lundbeck LLC | 1 | $24 |
| Alkermes, Inc. | 1 | $24 |
| Otsuka America Pharmaceutical, Inc. | 1 | $18 |
Products named: VRAYLAR, CAPLYTA, INGREZZA, Azstarys, REXULTI, UZEDY, TRINTELLIX, Dyanavel XR.
Industry payments across IL — which companies pay providers there.
